A LITTLE MORE WORLD. A LOT LESS EFFORT.111 editorial sources NOVEMBER 21, 2026
🇺🇸 United States / English

The world, in perspective.

Fresh headlines from around the world. Gaming, politics, technology and everything in between.

Auto refresh · 60 sec
World🇬🇷 GR
ERT NewsEL

Φάρμακα GLP-1: Προειδοποίηση FDA για σπάνια πάθηση που μπορεί να προκαλέσει τύφλωση

Νέες προειδοποιήσεις για τον κίνδυνο εμφάνισης μιας σπάνιας οφθαλμολογικής πάθησης, η οποία μπορεί να οδηγήσει σε αιφνίδια και μόνιμη απώλεια όρασης, ζητούν οι αμερικανικές αρχές να προστεθούν σε δημοφιλή φάρμακα για την παχυσαρκία και τον διαβήτη, όπως τα Ozempic, Wegovy, Mounjaro και Zepbound. Οι ειδικοί διευκρινίζουν, ωστόσο, ότι ο κίνδυνος είναι μικρός κ

World🇦🇪 AE
The NationalEN

FDA orders new warning on GLP-1 drugs over potential risk of blindness

The makers of GLP-1 weight loss drugs such as Ozempic, Wegovy and Mounjaro must update their safety guidance to describe a possible link to permanent vision loss , the US Food and Drug Administration has said. The regulator said that it based the decision on research that linked a rare eye condition, called non-arteritic anterior ischemic optic neuropathy (N

World🇧🇷 BR
G1PT

Bulas de Ozempic, Wegovy e outros da classe GLP-1 terão novo alerta sobre risco raro de perda da visão

FDA inclui alerta sobre perda de visão rara em medicamentos populares da classe GLP-1 Adobe Stock Medicamentos populares para perda de peso, incluindo Ozempic e Wegovy, passarão a trazer um novo alerta sobre um possível efeito colateral raro que, em alguns casos, pode levar à perda permanente da visão, anunciaram as autoridades de saúde dos Estados Unidos ne

Allnira republishes accessible articles under owner-declared permissions, with original authors, publishers and image credits. Automatic cloud imports run hourly; open pages check for updates every 15 seconds. Publication delays depend on each feed.